In particular, we demonstrate that PAD2 is important for the development of RA-ILD by promoting a profibrotic phenotype in RA-ILD fibroblasts, independent of ACPA, that is mitigated by treatment with SDC2. The gene discussed is PADI2; the disease is interstitial lung disease.